BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7102489)

  • 21. Random migration of leukocytes and phagocytic activity of neutrophils in patients with cancer of gastrointestinal tract at different clinical stages.
    Sulowicz W
    Rev Esp Oncol; 1983; 30(3):317-21. PubMed ID: 6571375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in cellular and humoral immunologic mechanisms in the postoperative period].
    Litarczek G; Tulbure D; Rădan A; Moţoiu I; Funduc I; Gayraud A; Oftez L; Dumitriu A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1989; 38(1):69-80. PubMed ID: 2527384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum immunoglobulin levels in cancer patients. II. Serum immunoglobulins and stage of tumor progress.
    Dostálová O; Schön E; Wagnerová M; Jelínek J; Wagner V
    Neoplasma; 1976; 23(1):95-102. PubMed ID: 1272476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.
    Atalay C; Atalay G; Altinok M
    Neoplasma; 2003; 50(3):185-90. PubMed ID: 12937851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunoglobulin levels in the serum and saliva of patients with laryngeal cancer].
    Kochetkova VA; Demidov VP; Zakharova NA; Bitiutskiĭ PG; Trofimov EI
    Vopr Onkol; 1981; 27(11):28-33. PubMed ID: 7336663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of human peritoneal immune cells in early stages of gastric and colon cancer.
    Olszewski WL; Kubicka U; Tarnowski W; Bielecki K; Ziolkowska A; Wesolowska A
    Surgery; 2007 Feb; 141(2):212-21. PubMed ID: 17263978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical surgery does not recover immunodeficiency associated with gastric cancer.
    Romano F; Caprotti R; Bravo AF; Conti M; Colombo G; Piacentini G; Uggeri F; Uggeri F
    J Exp Clin Cancer Res; 2003 Jun; 22(2):179-83. PubMed ID: 12866567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study.
    Franciosi CM; Piacentini MG; Conti M; Romano F; Musco F; Caprotti R; Rovelli F; Uggeri F
    Hepatogastroenterology; 2003; 50(49):297-300. PubMed ID: 12630045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative blastformation rate in gastrointestinal cancer patients.
    Miwa H; Orita K
    Acta Med Okayama; 1977 Aug; 31(4):257-62. PubMed ID: 145162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological changes in patients with colorectal cancer].
    Gürcüoğlu I; Ozbal Y; AritaşY
    Mikrobiyol Bul; 1984 Jan; 18(1):37-46. PubMed ID: 6611476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological studies in breast cancer.
    Lentino JA
    Allergol Immunopathol (Madr); 1975; 3(5):279-88. PubMed ID: 1227278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer.
    Guo E; Chen L; Xie Q; Chen J; Tang Z; Wu Y
    Ann Surg Oncol; 2007 Sep; 14(9):2528-34. PubMed ID: 17597347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma.
    Ren Z; Borody T; Pang G; Li LC; Dunkley M; Clancy R
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1338-43. PubMed ID: 16105118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
    Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum immunoglobulins IgG, IgA and IgM in patients with oral lichen ruber.
    Biocina-Lukenda D; Cekić-Arambasin A; Markeljević J; Buković D
    Coll Antropol; 2008 Mar; 32(1):161-3. PubMed ID: 18496909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.
    Moskal TL; Huang S; Ellis LM; Fritsche HA; Chakrabarty S
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):127-31. PubMed ID: 7742720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum immunoglobulins in colorectal cancer.
    Slater G; Papatestas AE; Shafir M; Aufses AH
    J Surg Oncol; 1980; 14(2):167-71. PubMed ID: 7392639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of humoral immunity in patients with gastric cancer.
    Wu CW; Lui WY; P'eng FK; Wang SR
    Asian Pac J Allergy Immunol; 1988 Jun; 6(1):7-10. PubMed ID: 3166645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.